Coordinator Entry Level

Key Objectives

  • Describe what research is and why it is done
  • Describe the background/history of the research process
  • Discuss terminology related to the research process
  • Review the IRB process and it’s impact on research
  • Explore the role of the nurse in the overall clinical research process
  • Summarize the four different Phases of research studies
  • Identify the elements of a drug-related study protocol and the value of following the appropriate protocol
  • Describe the importance of maintaining the regulatory binder during the research process
  • Identify the required and additional elements of the informed consent as it relates to the research process
  • Examine the criteria necessary to provide subject care while a subject is enrolled in a study to assure following the appropriate research protocol
  • Discuss the drawing of labs and the type of tubes used to collect specimens
  • Describe the process of Adverse Event (AE) reporting
  • Examine the process related to the nurse or pharmacist drug accountability during a research study
  • Describe the different types of source documents
  • Summarize the process for preparing for Clinical Research Associates (CRA) visits
  • Identify the research organizations, readings and websites
  • Critique a sample completed source document for errors and/or for missing documentation
  • Transcribe data from a sample source document onto a Case Report Form (CRF)
  • Demonstrate an understanding of basic knowledge related to the research process

Why Take This Course

The class is designed for those with zero to two years of research experience who are functioning as a study coordinator. It is also beneficial for those considering entry into this field or those who are relatively new to the conduct of clinical trials.

Course Content and CEU Information

This two-day course provides those with or without medical training immediate assistance in the role of a study coordinator. A comprehensive review of the drug development process, FDA/ICH requirements and basic terminology is matched with hands-on activities in protocol review, the informed consent process, and proper source document/CRF completion. The course involves group discussions and detailed exercises of materials presented.

Key Topics:

  • Basic Terminology and the Clinical Research Process
  • FDA/ICH Definitions, History and Requirements
  • Maintaining the Regulatory Binder
  • The Informed Consent Process
  • Generating Great Source Documents
  • Research Patient Care: Recruitment Through Study Determination
  • AE and SAE Reporting
  • Tips on Drug Accountability
  • Preparing for the Monitoring Visit
  • Critique of Mock Protocols and Informed Consents
  • Completion and Critique of Mock Source Documents and CRFs

CEUs Earned

  • 13.7 contact hours of nursing continuing education by the Louisiana State Nurses Association

Coordinator Intermediate Level

Key Objectives (Part One)

  • List the critical categories of research that can affect protocol feasibility at a study site.
  • Define the protocol characteristics that affect the success of study operations at a clinical site.
  • Identify the extraneous protocol factors that affect study nurse/coordinator workloads and general study conduct.
  • Identify Facility Logistics as it applies to protocol feasibility.
  • Demonstrate how to complete a protocol feasibility form.
  • Identify primary challenges with the research budget process.
  • Define internal and external cost factors within a protocol in order to enhance budget design.
  • Prepare a sample budget based on protocol cost factors.
  • Summarize study contract issues, which increase legal risks to study sites.
  • Define negotiating tips a nurse coordinator can use to maximize study budgets and contracts.
  • Identify time wasters.
  • Discuss ways to manage time effectively.
  • Discuss how to apply organizational skills to a study coordinator role.
  • Clearly set personal and professional life goals and be able to write the goals using affirmative language.
  • Clearly visualize their goals.
  • Create the “Relaxation Experience”
  • Describe the special informed consent scenarios that nurse coordinators face in clinical trials.
  • Identify the components of an informed consent standard operating procedure (SOP) that complies with FDA/ICH/GCP Standards and insures compliance.
  • Identify what can wrong with the consenting process.
  • Define the industry-reported salary ranges of study coordinators relative to training, experience, and geographic location.
  • Identify atypical benefits available to a nurse study coordinator.
  • Define the standard workload of a nurse study coordinator.
  • Demonstrate an understanding of intermediate knowledge related to the research process

Key Objectives (Part Two)

  • Describe “Good” traits of source documents.
  • Identify source document techniques that nurse coordinators can use to enhance a site’s internal quality assurance program.
  • Identify data inconsistencies.
  • List the integral parts of an internal audit plan.
  • Identify current industry trends regarding the use of technology in clinical trials.
  • Describe the impact of CRF Part II on the job of the nurse coordinator.
  • Define basic technology requirements for a study site.
  • Identify the four topic of research that maximizes investigator involvement.
  • Describe methods the nurse coordinator can institute to maximize investigator involvement.
  • Identify 4 maxims of communication.
  • Identify potential difficult communication situations in clinical trials.
  • Describe conflict resolution steps.
  • Define communication skills that reduce conflict in difficult situations.
  • Define the term mentor.
  • Define the characteristics of a mentor.
  • Describe how to develop a mentoring program.
  • Define the phrase “FDA Audit”, other audit terminology and expectations from a FDA Audit.
  • Discuss differences between and audit and a routine monitoring visit.
  • Identify types of FDA audits and how to participate in a FDA Audit.
  • Identify factors that affect trial placement by a study sponsor.
  • Define the methods nurse study coordinators may utilize to attract new trials.
  • List the therapeutic areas with the fastest growth opportunities in clinical trials.
  • Demonstrate an understanding of intermediate knowledge related to the research process.

Why Take This Course

This course is directed to those with greater than two years of coordinating experience or those who have completed the entry level training program. It is also beneficial to those interested in expanding their research knowledge in areas outside routing training.

Course Information

Our intermediate training program focuses on the more advance topics faced by study coordinators. The course is separated into two classes (parts) that may be taken independently of one another. Topics are reviewed utilizing real-world scenarios where class attendees participate in group discussions and learn industry best practices.

Part I Topics

  • Protocol Feasibility
  • Special Populations and the Informed Consent Process
  • Budgets and Contracts
  • Time Management
  • Brainstorming and Goal Setting
  • Clinical Research Salaries

Part II Topics

  • Improving Data Quality to Avoid Data Queries
  • Maximizing Investigator Involvement
  • Enhancing Communication Skills
  • Electronic Source Documents and eCRFs
  • Mentoring
  • FDA Inspections
  • Attracting New Trials: How to Grow Your Site

CEUs Earned

  • Part I: 8.7 contact hours of nursing continuing education by the Louisiana State Nurses Association

  • Part II: 8.7 contact hours of nursing continuing education by the Louisiana State Nurses Association

FDA Inspections: What You Can Expect in an Audit

    Goals

    • Each participant will gin additional insight into more advanced topics of clinical research.
    • Each participant will be able to utilize this information in his or her practice as a study coordinator.

    Objectives of the program:
    Participants will:

    • Define the phrase "FDA Audit", other audit terminology and expectations from a FDA Audit.
    • Discuss differences between an Audit and a routine monitoring visit.
    • Identify types of FDA audits and how to participate in a FDA Audit.

    CEUs Earned

    This Presenter-Directed Activity for 1.7 contact hours of nursing continuing education is approved by the Louisiana State Nurses Association (LSNA), an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

 

Homepage

Fear No Yellow Stickies Institute | Register Online / Store   Coordinator Training  Investigator Training  Monitoring  Training Dates  Newsletter  Just the Facts  Leadership Team  Gallery  Research Resources  Employment  Contact
Web Compatibility

Aureus Research Consultants, LLC

Back to the top